Showing results (21-30 of 851) with videos related to
Sort By:
Pageof 86
European Journal of Pharmacology|April 4, 1997
delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brainT H Burkey, R M Quock, P Consroe, et al.Journal of Environmental Quality|April 5, 2001
Bermudagrass fertilized with slow-release nitrogen sources. I. Nitrogen uptake and potential leaching lossesH M Quiroga-Garza, G A Picchioni, M D RemmengaEuropean Journal of Pharmacology|November 5, 1997
SR141716A is an inverse agonist at the human cannabinoid CB1 receptorR S Landsman, T H Burkey, P Consroe, et al.The International Journal of Neuroscience|January 1, 1988
Intraspinal opiates for treatment of intractable pain in the terminally ill cancer patientR P Iacono, J Linford, R Sandyk, et al.Life Sciences|March 13, 1998
AM630 is an inverse agonist at the human cannabinoid CB1 receptorR S Landsman, A Makriyannis, H Deng, et al.Pharmacology, Biochemistry, and Behavior|November 1, 1991
Controlled clinical trial of cannabidiol in Huntington's diseaseP Consroe, J Laguna, J Allender, et al.European Journal of Pharmacology|February 19, 1997
AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brainY Hosohata, R M Quock, K Hosohata, et al.NIDA Research Monograph|January 1, 1987
Stereochemical requirements for cannabimimetic activityR Mechoulam, N Lander, M Srebnik, et al.Neuroreport|January 31, 1996
Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociceptionS A Edsall, R J Knapp, T W Vanderah, et al.Experientia|September 15, 1988
Enantiomeric cannabinoids: stereospecificity of psychotropic activityR Mechoulam, J J Feigenbaum, N Lander, et al.Pageof 86